Literature DB >> 25888600

Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance.

Eunjung Lee1, Dae Young Jung1, Jong Hun Kim1, Payal R Patel1, Xiaodi Hu1, Yongjin Lee1, Yoshihiro Azuma1, Hsun-Fan Wang1, Nicholas Tsitsilianos1, Umber Shafiq1, Jung Yeon Kwon1, Hyong Joo Lee1, Ki Won Lee2, Jason K Kim2.   

Abstract

Insulin resistance is a major characteristic of obesity and type 2 diabetes, but the underlying mechanism is unclear. Recent studies have shown a metabolic role of capsaicin that may be mediated via the transient receptor potential vanilloid type-1 (TRPV1) channel. In this study, TRPV1 knockout (KO) and wild-type (WT) mice (as controls) were fed a high-fat diet (HFD), and metabolic studies were performed to measure insulin and leptin action. The TRPV1 KO mice became more obese than the WT mice after HFD, partly attributed to altered energy balance and leptin resistance in the KO mice. The hyperinsulinemic-euglycemic clamp experiment showed that the TRPV1 KO mice were more insulin resistant after HFD because of the ∼40% reduction in glucose metabolism in the white and brown adipose tissue, compared with that in the WT mice. Leptin treatment failed to suppress food intake, and leptin-mediated hypothalamic signal transducer and activator of transcription (STAT)-3 activity was blunted in the TRPV1 KO mice. We also found that the TRPV1 KO mice were more obese and insulin resistant than the WT mice at 9 mo of age. Taken together, these results indicate that lacking TRPV1 exacerbates the obesity and insulin resistance associated with an HFD and aging, and our findings further suggest that TRPV1 has a major role in regulating glucose metabolism and hypothalamic leptin's effects in obesity. © FASEB.

Entities:  

Keywords:  aging; capsaicin; glucose metabolism; hyperinsulinemic-euglycemic clamp

Mesh:

Substances:

Year:  2015        PMID: 25888600      PMCID: PMC4511197          DOI: 10.1096/fj.14-268300

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  38 in total

1.  Dairy calcium is related to changes in body composition during a two-year exercise intervention in young women.

Authors:  Y C Lin; R M Lyle; L D McCabe; G P McCabe; C M Weaver; D Teegarden
Journal:  J Am Coll Nutr       Date:  2000 Nov-Dec       Impact factor: 3.169

2.  The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity.

Authors:  Roberto Coppari; Masumi Ichinose; Charlotte E Lee; Abigail E Pullen; Christopher D Kenny; Robert A McGovern; Vinsee Tang; Shun M Liu; Thomas Ludwig; Streamson C Chua; Bradford B Lowell; Joel K Elmquist
Journal:  Cell Metab       Date:  2005-01       Impact factor: 27.287

Review 3.  Adipocytokines and the metabolic complications of obesity.

Authors:  Neda Rasouli; Philip A Kern
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

4.  Leptin-dependent control of glucose balance and locomotor activity by POMC neurons.

Authors:  Lihong Huo; Kevin Gamber; Sarah Greeley; Jose Silva; Nicholas Huntoon; Xing-Hong Leng; Christian Bjørbaek
Journal:  Cell Metab       Date:  2009-06       Impact factor: 27.287

5.  Effects of capsaicin, green tea and CH-19 sweet pepper on appetite and energy intake in humans in negative and positive energy balance.

Authors:  H C Reinbach; A Smeets; T Martinussen; P Møller; M S Westerterp-Plantenga
Journal:  Clin Nutr       Date:  2009-04-03       Impact factor: 7.324

6.  TRPV1-null mice are protected from diet-induced obesity.

Authors:  Arianne L Motter; Gerard P Ahern
Journal:  FEBS Lett       Date:  2008-05-27       Impact factor: 4.124

Review 7.  The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not.

Authors:  Andrej A Romanovsky; Maria C Almeida; Andras Garami; Alexandre A Steiner; Mark H Norman; Shaun F Morrison; Kazuhiro Nakamura; Jeffrey J Burmeister; Tatiane B Nucci
Journal:  Pharmacol Rev       Date:  2009-09-11       Impact factor: 25.468

8.  Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.

Authors:  Li Li Zhang; Dao Yan Liu; Li Qun Ma; Zhi Dan Luo; Ting Bing Cao; Jian Zhong; Zhen Cheng Yan; Li Juan Wang; Zhi Gang Zhao; Shan Jun Zhu; Mark Schrader; Florian Thilo; Zhi Ming Zhu; Martin Tepel
Journal:  Circ Res       Date:  2007-03-08       Impact factor: 17.367

Review 9.  Know thy neighbor: a survey of diseases and complex syndromes that map to chromosomal regions encoding TRP channels.

Authors:  J Abramowitz; L Birnbaumer
Journal:  Handb Exp Pharmacol       Date:  2007

10.  Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle.

Authors:  Eun-Gyoung Hong; Hwi Jin Ko; You-Ree Cho; Hyo-Jeong Kim; Zhexi Ma; Tim Y Yu; Randall H Friedline; Evelyn Kurt-Jones; Robert Finberg; Matthew A Fischer; Erica L Granger; Christopher C Norbury; Stephen D Hauschka; William M Philbrick; Chun-Geun Lee; Jack A Elias; Jason K Kim
Journal:  Diabetes       Date:  2009-08-18       Impact factor: 9.461

View more
  51 in total

1.  A TRPV1-to-secretagogin regulatory axis controls pancreatic β-cell survival by modulating protein turnover.

Authors:  Katarzyna Malenczyk; Fatima Girach; Edit Szodorai; Petter Storm; Åsa Segerstolpe; Giuseppe Tortoriello; Robert Schnell; Jan Mulder; Roman A Romanov; Erzsébet Borók; Fabiana Piscitelli; Vincenzo Di Marzo; Gábor Szabó; Rickard Sandberg; Stefan Kubicek; Gert Lubec; Tomas Hökfelt; Ludwig Wagner; Leif Groop; Tibor Harkany
Journal:  EMBO J       Date:  2017-06-21       Impact factor: 11.598

Review 2.  Leptin applications in 2015: what have we learned about leptin and obesity?

Authors:  Olivia M Farr; Anna Gavrieli; Christos S Mantzoros
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-10       Impact factor: 3.243

3.  TRPV1-Targeted Drugs in Development for Human Pain Conditions.

Authors:  Mircea Iftinca; Manon Defaye; Christophe Altier
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

Review 4.  Adipose Tissue and Energy Expenditure: Central and Peripheral Neural Activation Pathways.

Authors:  Magdalena Blaszkiewicz; Kristy L Townsend
Journal:  Curr Obes Rep       Date:  2016-06

5.  Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling.

Authors:  Claudia Manca; Besma Boubertakh; Nadine Leblanc; Thomas Deschênes; Sebastien Lacroix; Cyril Martin; Alain Houde; Alain Veilleux; Nicolas Flamand; Giulio G Muccioli; Frédéric Raymond; Patrice D Cani; Vincenzo Di Marzo; Cristoforo Silvestri
Journal:  J Lipid Res       Date:  2019-11-05       Impact factor: 5.922

6.  Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity.

Authors:  Li-Hao Huang; Elaina M Melton; Haibo Li; Paul Sohn; DaeYoung Jung; Ching-Yi Tsai; Tian Ma; Hiroyuki Sano; HyeKyung Ha; Randall H Friedline; Jason K Kim; Edward Usherwood; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-13       Impact factor: 4.310

Review 7.  The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus.

Authors:  Alain Veilleux; Vincenzo Di Marzo; Cristoforo Silvestri
Journal:  Curr Diab Rep       Date:  2019-11-04       Impact factor: 4.810

8.  Capsaicin induces browning of white adipose tissue and counters obesity by activating TRPV1 channel-dependent mechanisms.

Authors:  Padmamalini Baskaran; Vivek Krishnan; Jun Ren; Baskaran Thyagarajan
Journal:  Br J Pharmacol       Date:  2016-06-21       Impact factor: 8.739

Review 9.  Potential therapeutic value of TRPV1 and TRPA1 in diabetes mellitus and obesity.

Authors:  Andrei V Derbenev; Andrea Zsombok
Journal:  Semin Immunopathol       Date:  2015-09-24       Impact factor: 9.623

10.  Lack of TRPV2 impairs thermogenesis in mouse brown adipose tissue.

Authors:  Wuping Sun; Kunitoshi Uchida; Yoshiro Suzuki; Yiming Zhou; Minji Kim; Yasunori Takayama; Nobuyuki Takahashi; Tsuyoshi Goto; Shigeo Wakabayashi; Teruo Kawada; Yuko Iwata; Makoto Tominaga
Journal:  EMBO Rep       Date:  2016-02-11       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.